Crystallization and preliminary X-ray data analysis of beta-alanine synthase from Drosophila melanogaster

Research output: Contribution to journalArticle

Abstract

beta-Alanine synthase catalyzes the last step in the reductive degradation pathway for uracil and thymine, which represents the main clearance route for the widely used anticancer drug 5-fluorouracil. Crystals of the recombinant enzyme from Drosophila melanogaster, which is closely related to the human enzyme, were obtained by the hanging-drop vapour-diffusion method. They diffracted to 3.3 angstrom at a synchrotron-radiation source, belong to space group C2 (unit-cell parameters a = 278.9, b = 95.0, c = 199.3 angstrom, beta = 125.8 degrees) and contain 8-10 molecules per asymmetric unit.

Details

Authors
  • Stina Lundgren
  • Birgit Andersen
  • Jure Piskur
  • Doreen Dobritzsch
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Biological Sciences
Original languageEnglish
Pages (from-to)874-877
JournalActa Crystallographica. Section F: Structural Biology and Crystallization Communications
Volume63
Publication statusPublished - 2007
Publication categoryResearch
Peer-reviewedYes